文献速递皮肤肿瘤毛发、甲与色素性疾病

改良削切术联合甲窗技术治疗纵向黑甲:67例方法评估

Modified shave surgery combined with nail window technique for the treatment of longitudinal melanonychia: Evaluation of the method on a series of 67 cases.
PubMed 文献 · J Am Acad Dermatol · 2019-03-28

本研究回顾性分析67例纵向黑甲(LM)患者,采用改良削切手术联合纵向条带甲窗技术治疗。所有病例均获得病理诊断,60例可评估术后结局:45例(75.0%)无术后甲营养不良,仅8例(13.3%)出现色素复发。结论认为该技术是LM的优选管理方法,术后甲营养不良和色素复发有限。

要点

  • 改良削切术联合甲窗技术可用于纵向黑甲的诊断与治疗。
  • 术后甲营养不良发生率低,75.0%病例无甲营养不良。
  • 色素复发率较低,仅13.3%病例出现复发。

核心结论

  • 改良削切手术联合甲窗技术是纵向黑甲病例的优选管理方法,术后甲营养不良和色素复发有限。

研究设计与样本

  • 回顾性研究,纳入2015年3月至2018年6月期间接受削切手术联合纵向条带甲窗技术治疗的67例纵向黑甲患者。

主要发现

  • 所有病例均获得病理诊断,60例可评估术后结局。
  • 45例(75.0%)无术后甲营养不良。
  • 仅8例(13.3%)出现甲色素复发。

临床怎么用

  • 对于纵向黑甲患者,可考虑采用改良削切手术联合甲窗技术进行诊疗,以获取病理诊断并降低术后甲营养不良和色素复发风险。

局限性

  • 本研究为回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nail matrix histopathologic examination is still the criterion standard to diagnose longitudinal melanonychia (LM). OBJECTIVE: To introduce modified shave surgery combined with the nail window technique for managing LM and evaluate the postoperative outcome of the procedure. METHODS: We retrospectively reviewed the medical records of 67 patients with LM who underwent shave surgery combined with the longitudinal-strip nail window technique at our institution from March 2015 to June 2018. RESULTS: Pathologic diagnosis was accessible in all cases, and 60 cases were assessable for the postoperative outcomes. A total of 45 cases (75.0%) had no postoperative nail dystrophy, and recurrence of nail pigmentation was found in only 8 cases (13.3%). LIMITATIONS: This was a retrospective study. CONCLUSION: Modified shave surgery combined with the nail window technique is the preferable management for LM cases, with limited postoperative nail dystrophy and recurrence of pigmentation.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Zhou Y, Chen W, Liu ZR, et al. Modified shave surgery combined with nail window technique for the treatment of longitudinal melanonychia: Evaluation of the method on a series of 67 cases. J Am Acad Dermatol. 2019. PMID: 30930088. doi:10.1016/j.jaad.2019.03.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。